Westergaard J G, Teisner B, Hau J, Grudzinskas J G
Br J Obstet Gynaecol. 1984 Dec;91(12):1224-9. doi: 10.1111/j.1471-0528.1984.tb04741.x.
Maternal serum levels of pregnancy-associated plasma protein A (PAPP-A), human placental lactogen (hPL) and schwangerschafts-protein 1 (SP1) were measured serially during the second and third trimesters in 753 women with a normal pregnancy when recruited during the second trimester. Thirty-seven pregnancies were complicated by pregnancy-related hypertension after 28 weeks gestation. Maternal levels of PAPP-A and SP1, and trends of levels in individual patients, could generally not be distinguished from those seen in patients with a normal pregnancy, and were unrelated to the time of onset of the disease, its severity or the occurrence of other complications with one exception, in which decreased levels of SP1 and hPL were seen. Mean levels of hPL were significantly lower (P less than 0.05) at 35 weeks gestation. These data suggest that the measurement of the placental proteins examined here is of no value in the prediction of occurrence of pregnancy-related hypertension.
在孕中期招募的753例正常妊娠妇女中,在孕中期和孕晚期连续检测母体血清妊娠相关血浆蛋白A(PAPP-A)、人胎盘催乳素(hPL)和妊娠蛋白1(SP1)水平。37例妊娠在妊娠28周后并发妊娠相关高血压。PAPP-A和SP1的母体水平以及个体患者的水平趋势,一般与正常妊娠患者的水平无法区分,且与疾病发作时间、严重程度或其他并发症的发生无关,但有一个例外,即观察到SP1和hPL水平降低。孕35周时hPL的平均水平显著降低(P<0.05)。这些数据表明,此处检测的胎盘蛋白测量对预测妊娠相关高血压的发生没有价值。